Literature DB >> 805188

Effectiveness of achievable urinary concentrations of tetracyclines against "tetracycline-resistant" pathogenic bacteria.

D M Musher, J N Minuth, S B Thorsteinsson, T Holmes.   

Abstract

Hospitalized patients with urinary tract infections caused by Pseudomonas aeruginosa or other bacterial pathogens are frequently treated with parenteral antibiotics such as gentamicin. Many of these organisms are shown by Kirby-Bauer disk sensitivity testing to be resistant to tetracycline. One hundred seventy-one such tetracycline-resistant bacterial isolates were studied; 84% were found to be sensitive to achievable urinary concentrations of tetracycline. Two patients with long-standing chronic urinary tract infection with Pseudomonas were treated with tetracycline for a year and a half with excellent results. In a pilot clinical trial, eight of 12 hospitalized patients with urinary tract infection were treated successfully with tetracycline without regard to disk sensitivity data. Institution of tetracycline as soon as the microscopic diagnosis of urinary tract infection is made might be an acceptable empiric approach to the treatment of urinary infection in hospitalized patients who do not show evidence of sepsis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 805188     DOI: 10.1093/infdis/131.supplement.s40

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-06       Impact factor: 3.267

Review 2.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 3.267

4.  Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

Authors:  B A Cunha; C B Cunha; B Lam; J Giuga; J Chin; V F Zafonte; S Gerson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-02       Impact factor: 3.267

5.  Urinary tract infection: significance and management.

Authors:  N E Tolkoff-Rubin; R H Rubin
Journal:  Bull N Y Acad Med       Date:  1986-03

Review 6.  Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.

Authors:  Andrew Chou; Elwyn Welch; Andrew Hunter; Barbara W Trautner
Journal:  Drugs       Date:  2022-03-14       Impact factor: 11.431

7.  In vitro activity of spectinomycin against recent urinary tract isolates.

Authors:  R J Fass; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

8.  Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli.

Authors:  Amit Gaurav; Varsha Gupta; Sandeep K Shrivastava; Ranjana Pathania
Journal:  Commun Biol       Date:  2021-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.